Swedish Orphan Biovitrum AB (publ) provided revenue guidance for the year 2024. For the period, the company anticipated revenue to grow by a high single-digit percentage at CER.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
288.6 SEK | +1.48% | +5.79% | +8.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.09% | 9.41B | |
+0.99% | 91.72B | |
0.00% | 39.44B | |
-10.35% | 34.47B | |
+64.64% | 26.7B | |
-16.15% | 15.13B | |
-6.98% | 13.27B | |
-11.77% | 11.74B | |
-49.19% | 10.54B | |
+141.62% | 9.22B |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB
- Swedish Orphan Biovitrum AB Provides Revenue Guidance for the Year 2024